Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,268 | -9,005 | -5,732 | -2,537 | -10,116 |
| Depreciation Amortization | 87 | 74 | 56 | 33 | 201 |
| Accounts payable and accrued liabilities | -363 | 368 | -318 | -265 | -1,429 |
| Other Working Capital | 709 | 546 | -451 | -925 | -2,781 |
| Other Operating Activity | 945 | -63 | 521 | 366 | 1,957 |
| Operating Cash Flow | $-12,890 | $-8,080 | $-5,924 | $-3,328 | $-12,168 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -14 | -14 | -14 | -9 |
| Investing Cash Flow | $-14 | $-14 | $-14 | $-14 | $-9 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 74,002 | 74,002 | 74,002 | 74,002 | 3,359 |
| Financing Cash Flow | $74,002 | $74,002 | $74,002 | $74,002 | $3,359 |
| Beginning Cash Position | 6,227 | 6,227 | 6,227 | 6,227 | 15,045 |
| End Cash Position | 67,325 | 72,135 | 74,291 | 76,887 | 6,227 |
| Net Cash Flow | $61,098 | $65,908 | $68,064 | $70,660 | $-8,818 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,890 | -8,080 | -5,924 | -3,328 | -12,168 |
| Capital Expenditure | -14 | -14 | -14 | -14 | -9 |
| Free Cash Flow | -12,904 | -8,094 | -5,938 | -3,342 | -12,177 |